Exploring the native human antibody repertoire to create antiviral therapeutics
- PMID: 17990793
- PMCID: PMC7121815
- DOI: 10.1007/978-3-540-72146-8_6
Exploring the native human antibody repertoire to create antiviral therapeutics
Abstract
Native human antibodies are defined as those that arise naturally as the result of the functioning of an intact human immune system. The utility of native antibodies for the treatment of human viral diseases has been established through experience with hyperimmune human globulins. Native antibodies, as a class, differ in some respects from those obtained by recombinant library methods (phage or transgenic mouse) and possess distinct properties that may make them ideal therapeutics for human viral diseases. Methods for cloning native human antibodies have been beset by technical problems, yet many antibodies specific for viral antigens have been cloned. In the present review, we discuss native human antibodies and ongoing improvements in cloning methods that should facilitate the creation of novel, potent antiviral therapeutics obtained from the native human antibody repertoire.
Similar articles
-
Antibodies for the prevention and treatment of viral diseases.Antiviral Res. 2000 Aug;47(2):57-77. doi: 10.1016/s0166-3542(00)00111-x. Antiviral Res. 2000. PMID: 10996394 Review.
-
High efficiency creation of human monoclonal antibody-producing hybridomas.J Immunol Methods. 2004 Aug;291(1-2):109-22. doi: 10.1016/j.jim.2004.05.005. J Immunol Methods. 2004. PMID: 15345310
-
Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.Infect Agents Dis. 1993 Jun;2(3):118-31. Infect Agents Dis. 1993. PMID: 8173784 Review.
-
[Viral infection].Nihon Rinsho. 2002 Mar;60(3):585-90. Nihon Rinsho. 2002. PMID: 11904977 Review. Japanese.
-
Monoclonal antibody therapy and viral infections: update and beyond.Clin Microbiol Infect. 2011 Dec;17(12):1757-8. doi: 10.1111/j.1469-0691.2011.03670.x. Epub 2011 Oct 19. Clin Microbiol Infect. 2011. PMID: 22010631 No abstract available.
Cited by
-
Prophylaxis and therapy for Chikungunya virus infection.J Infect Dis. 2009 Aug 15;200(4):516-23. doi: 10.1086/600381. J Infect Dis. 2009. PMID: 19572805 Free PMC article.
-
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.ACS Chem Biol. 2012 Jul 20;7(7):1139-51. doi: 10.1021/cb300119g. Epub 2012 Jul 3. ACS Chem Biol. 2012. PMID: 22758917 Free PMC article.
-
Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals.MAbs. 2016 Aug-Sep;8(6):1035-44. doi: 10.1080/19420862.2016.1190059. Epub 2016 May 25. MAbs. 2016. PMID: 27224530 Free PMC article.
References
-
- Ames RS, Tornetta MA, McMillan LJ, Kaiser KF, Holmes SD, Appelbaum E, Cusimano DM, Theisen TW, Gross MS, Jones CS, et al. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library. J Immunol. 1995;154:6355–6364. - PubMed
-
- Andris JS, Ehrlich PH, Ostberg L, Capra JD. Probing the human antibody repertoire to exogenous antigens. Characterization of the H and L chain V region gene segments from anti-hepatitis B virus antibodies. J Immunol. 1992;149:4053–4059. - PubMed
-
- Arakelov S, Gorny MK, Williams C, Riggin CH, Brady F, Collett MS, Zolla-Pazner S. Generation of neutralizing anti-B19 parvovirus human monoclonal antibodies from patients infected with human immunodeficiency virus. J Infect Dis. 1993;168:580–585. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical